{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:17:14Z","timestamp":1789802234645,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":613,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Remote haemodynamic monitoring with an implantable pulmonary artery (PA) sensor has been shown to reduce heart failure (HF) hospitalizations and improve quality of life. Cost-effectiveness analyses studying the value of remote haemodynamic monitoring in a European healthcare system with a contemporary standard care group are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A Markov model was developed to estimate the cost-effectiveness of PA-guided therapy compared to the standard of care based upon patient-level data of the MONITOR-HF trial performed in the Netherlands in patients with chronic HF (New York Heart Association class III and at least one previous HF hospitalization). Cost-effectiveness was measured as the incremental cost per quality-adjusted life year (QALY) gained from the Dutch societal perspective with a lifetime horizon which encompasses a wide variety of costs including costs of hospitalizations, monitoring time, telephone contacts, laboratory assessments, and drug changes in both treatment groups. In the base-case analysis, PA-guided therapy increased costs compared to standard of care by \u20ac12\u2009121. The QALYs per patient for PA-guided therapy and standard of care was 4.07 and 3.481, respectively, reflecting a gain of 0.58 QALYs. The resulting incremental cost-effectiveness ratio was \u20ac20\u2009753 per QALY, which is below the Dutch willingness-to-pay threshold of \u20ac50\u2009000 per QALY gained for HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current cost-effectiveness study suggests that remote haemodynamic monitoring with PA-guided therapy on top of standard care is likely to be cost-effective for patients with symptomatic moderate-to-severe HF in the Netherlands.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3213","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T07:13:32Z","timestamp":1711955612000},"page":"1189-1198","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-Effectiveness of Remote Haemodynamic Monitoring by an Implantable Pulmonary Artery Pressure Monitoring Sensor (CardioMEMS-HF System) in Chronic Heart Failure in the Netherlands"],"prefix":"10.1093","volume":"26","author":[{"given":"Hamraz","family":"Mokri","sequence":"first","affiliation":[{"name":"Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal R.D.","family":"Clephas","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Baal","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.","family":"Brugts","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen P.M.H.","family":"Rutten-van M\u00f6lken","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam , Rotterdam ,","place":["The Netherlands"]},{"name":"Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"2026010913055180000_ejhf3213-bib-0001","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1093\/eurheartj\/ehad280","article-title":"Telemonitoring for heart failure: A meta-analysis","volume":"44","author":"Scholte","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010913055180000_ejhf3213-bib-0002","doi-asserted-by":"crossref","DOI":"10.3390\/s23031364","article-title":"Recent advances in remote pulmonary artery pressure monitoring for patients with chronic heart failure: Current evidence and future perspectives","volume":"23","author":"Clephas","year":"2023","journal-title":"Sensors (Basel)"},{"key":"2026010913055180000_ejhf3213-bib-0003","article-title":"Benefits of remote hemodynamic monitoring in heart failure","author":"Clephas","journal-title":"Trends Cardiovasc Med"},{"key":"2026010913055180000_ejhf3213-bib-0004","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2026010913055180000_ejhf3213-bib-0005","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): A randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"key":"2026010913055180000_ejhf3213-bib-0006","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): A randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"key":"2026010913055180000_ejhf3213-bib-0007","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.1943","article-title":"Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: The CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF)","volume":"22","author":"Angermann","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ehf2.13748","article-title":"Real-world evidence in a national health service: Results of the UK CardioMEMS HF System Post-Market Study","volume":"9","author":"Cowie","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cardfail.2022.10.422","article-title":"Sustained reduction in pulmonary artery pressures and hospitalizations during 2\u2009years of ambulatory monitoring","volume":"29","author":"Heywood","year":"2023","journal-title":"J Card Fail"},{"key":"2026010913055180000_ejhf3213-bib-0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ejhf.747","article-title":"The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: A European perspective","volume":"19","author":"Cowie","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0011","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/ehf2.14496","article-title":"Real-time pulmonary artery pressure monitoring in heart failure patients: An updated cost-effectiveness analysis","volume":"10","author":"Cowie","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ejhf.642","article-title":"Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial","volume":"19","author":"Martinson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0013","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchf.2015.12.015","article-title":"Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure","volume":"4","author":"Sandhu","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0014","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.22696","article-title":"Cost-effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system","volume":"40","author":"Schmier","year":"2017","journal-title":"Clin Cardiol"},{"key":"2026010913055180000_ejhf3213-bib-0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12471-019-01341-9","article-title":"A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial","volume":"28","author":"Brugts","year":"2020","journal-title":"Neth Heart J"},{"key":"2026010913055180000_ejhf3213-bib-0016","volume-title":"Costing Manual: Methodology of Costing Research and Reference Prices for Economic Evaluations in Healthcare","author":"Hakkaart-van Roijen","year":"2015"},{"key":"2026010913055180000_ejhf3213-bib-0017","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"key":"2026010913055180000_ejhf3213-bib-0018","volume-title":"Manual iMTA Medical Cost Questionnaire (iMCQ)","year":"2018"},{"key":"2026010913055180000_ejhf3213-bib-0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187477","article-title":"Update of the Dutch manual for costing studies in health care","volume":"12","author":"Kanters","year":"2017","journal-title":"PLoS One"},{"key":"2026010913055180000_ejhf3213-bib-0020","volume-title":"Consumer prices; price index 2015","author":"Statline","year":"2023"},{"key":"2026010913055180000_ejhf3213-bib-0021","author":"DBC Zorgproducten","year":"2023"},{"key":"2026010913055180000_ejhf3213-bib-0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0272989X221103163","article-title":"An introductory tutorial on cohort state-transition models in R using a cost-effectiveness analysis example","volume":"43","author":"Alarid-Escudero","year":"2023","journal-title":"Med Decis Making"},{"key":"2026010913055180000_ejhf3213-bib-0023","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1093\/eurheartj\/ehad346","article-title":"Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: A meta-analysis of three randomized controlled trials","volume":"44","author":"Clephas","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010913055180000_ejhf3213-bib-0024","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/eurjhf\/hfq232","article-title":"Economic impact of remote patient monitoring: An integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure","volume":"13","author":"Klersy","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0025","doi-asserted-by":"crossref","DOI":"10.1186\/1478-7954-9-17","article-title":"Decomposing cross-country differences in quality adjusted life expectancy: The impact of value sets","volume":"9","author":"Heijink","year":"2011","journal-title":"Popul Health Metr"},{"key":"2026010913055180000_ejhf3213-bib-0026","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2017.03.009","article-title":"Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in \"real-world\" clinical practice","volume":"69","author":"Desai","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026010913055180000_ejhf3213-bib-0027","article-title":"Twelve-month follow-up results from the SIRONA 2 clinical trial","author":"Sharif","journal-title":"ESC Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913055180000_ejhf3213-bib-0029","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2023.11.030","article-title":"Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction","volume":"83","author":"Lindenfeld","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/5\/1189\/65512823\/eurjhf_26_5_1189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/5\/1189\/65512823\/eurjhf_26_5_1189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:06:59Z","timestamp":1767982019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/26\/5\/1189\/8328715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3213","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"2023-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}